McCulloch Kevin — SEC Form 4 filings
SEC reporting owner CIK 2031695. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-08-02 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 25,000 shares, $109,475 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 135,000 shares, $1,090,059 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 90,000 shares @ $8.03 ($722,511) in Xeris Biopharma Holdings, Inc., filed 2026-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | 15 | 1 leg · 25,000 sh · $109,475 | 4 legs · 135,000 sh · $1,090,059 | 21 |
Form 4 filings — McCulloch Kevin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 15,000 @ $8.49 | EDGAR |
| 2026-08-21 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 21,918 @ $8.08 | EDGAR |
| 2026-08-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 15,000 @ $8.02 | EDGAR |
| 2026-07-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 90,000 @ $8.03 | EDGAR |
| 2026-03-16 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Option exercise (M): 48,894 @ $4.09 · Option exercise (M): 4 @ $3.94 · Option exercise (M): 48,894 (derivative) @ $4.09 · Option exercise (M): 4 (derivative) @ $3.94 | EDGAR |
| 2026-02-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 168,463 @ $0 · Tax withholding (F): 68,454 @ $7.36 · Tax withholding (F): 30,289 @ $7.36 · Tax withholding (F): 27,319 @ $7.36 · Grant/award (A): 225,225 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 15,000 @ $8 | EDGAR |
| 2025-10-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 733 @ $8.31 | EDGAR |
| 2025-09-15 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Other (J): 2,000 @ $0 | EDGAR |
| 2025-08-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 14,651 @ $5.38 | EDGAR |
| 2025-06-16 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 25,000 @ $4.38 | EDGAR |
| 2025-04-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 733 @ $5.15 | EDGAR |
| 2025-02-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 29,300 @ $3.56 · Tax withholding (F): 48,834 @ $3.56 · Grant/award (A): 185,000 @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 24,501 @ $3.61 | EDGAR |
| 2024-08-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 150,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2031695 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →